CHO.SET LIBRARY Trademark

Trademark Overview


On Thursday, December 19, 2024, a trademark application was filed for CHO.SET LIBRARY with the United States Patent and Trademark Office. The USPTO has given the CHO.SET LIBRARY trademark a serial number of 79420492. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, January 29, 2026. This trademark is owned by SYNGENSYS LIMITED. The CHO.SET LIBRARY trademark is filed in the Chemical Products, Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical analysis for diagnosis and treatment of persons; medical, gene and cell data analysis for diagnosis and treatment of persons; medical analysis services relating to the treatment of persons, namely, conducting of studies and analyses on health of persons, medicines for medical diagnostic and treatment purposes and for gene and cell therapy; medical screening; medical advisory services, namely, preparation of medical reports and medical recommendations; carrying out disease diagnostics; advisory services in the field of health care, and medical services in the nature of gene and cell therapy; medical diagnosis services; stem cell therapy services; cell bank and tissue bank services in the nature of stem cell storage; stem cell bank services; cultured cell bank services for medical transplantation; medical treatment using cultured cells; RNA and DNA analysis for cancer diagnosis and prognosis; medical services relating to the removal, treatment and processing of human genes and ce...

Proteins for use in recombinant DNA technology other than for medical use; synthetic promoters for gene expression for scientific, research, or manufacturing purposes; enzymes other than for medical use for use in the continuous homogenous isothermal amplifications of specific DNA templates; enzymes for detecting protein fractions other than for medical use; proteins for binding antibodies other than for medical or veterinary use; chemical preparations for use in DNA analysis other than medical or veterinary use; enzymes for use in detecting proteins other than for medical or veterinary use; enzymes other than for medical use for use in the continuous homogenous isothermal amplifications of specific MA templates; nucleic acid sequencing programs namely, DNA or RNA which have imbedded programs which direct cellular processes, other than for medical or veterinary use; enzymes for labelling protein fractions other than for medical use; nucleic recombinant acids other than for medical or v...

Biopharmaceutical preparations for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; synthetic promoters for the production of secreted proteins by cell culture for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; protein synthesis inhibitors for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; human plasma protein for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related dis...

Collection of information into computer databases, particularly commercial, scientific, health, gene and cell information; collection of data into computer databases, particularly commercial, scientific, health, gene and cell data; computerized database management; computerized file management; management of files and records related to the health status of individuals, molecules and formulation for medical use, as well as medicines and medical research; management of computerized files, namely, data retrieval services; statistical information compilation services into computer databases; data processing services; data processing via computer; management of computer files and data stored in electronic format, on hardware, and i n products for medical and non-medical research and analysis; management of computerized files, namely, collating and maintaining computer files and data in electronic format, in the field of materials and products for medical and non-medical research and analys...

Structural and functional analysis of genomes; genetic fingerprinting; genetic research; research in the field of gene therapy; laboratory research in the field of gene expression; analysis in the field of molecular biology for research purposes; biochemical analysis for research purposes; research and development services in the field of gene expression systems; research and development services in the field of genes and cells; biotechnology research; scientific research in the field of genetics and genetic engineering; biological analysis for research purposes; genetic mapping for scientific purposes; genetic engineering services; biotechnology testing, namely, testing in the field of biopharmaceutical development; biochemical research and development; scientific and technical analysis and research in the field of biotechnology; computer testing and analysis, namely, testing and analysis of computer systems; quality control for others and auditing in the nature technical analysis and...
cho.set library

General Information


Serial Number79420492
Word MarkCHO.SET LIBRARY
Filing DateThursday, December 19, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, January 29, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical analysis for diagnosis and treatment of persons; medical, gene and cell data analysis for diagnosis and treatment of persons; medical analysis services relating to the treatment of persons, namely, conducting of studies and analyses on health of persons, medicines for medical diagnostic and treatment purposes and for gene and cell therapy; medical screening; medical advisory services, namely, preparation of medical reports and medical recommendations; carrying out disease diagnostics; advisory services in the field of health care, and medical services in the nature of gene and cell therapy; medical diagnosis services; stem cell therapy services; cell bank and tissue bank services in the nature of stem cell storage; stem cell bank services; cultured cell bank services for medical transplantation; medical treatment using cultured cells; RNA and DNA analysis for cancer diagnosis and prognosis; medical services relating to the removal, treatment and processing of human genes and cells for the diagnosis and treatment of persons; information and advice concerning all the aforesaid services.
NOT AVAILABLE"CHO" and "LIBRARY"
Goods and ServicesProteins for use in recombinant DNA technology other than for medical use; synthetic promoters for gene expression for scientific, research, or manufacturing purposes; enzymes other than for medical use for use in the continuous homogenous isothermal amplifications of specific DNA templates; enzymes for detecting protein fractions other than for medical use; proteins for binding antibodies other than for medical or veterinary use; chemical preparations for use in DNA analysis other than medical or veterinary use; enzymes for use in detecting proteins other than for medical or veterinary use; enzymes other than for medical use for use in the continuous homogenous isothermal amplifications of specific MA templates; nucleic acid sequencing programs namely, DNA or RNA which have imbedded programs which direct cellular processes, other than for medical or veterinary use; enzymes for labelling protein fractions other than for medical use; nucleic recombinant acids other than for medical or veterinary purposes; enzymes for measuring proteins other than for medical use
Goods and ServicesBiopharmaceutical preparations for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; synthetic promoters for the production of secreted proteins by cell culture for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; protein synthesis inhibitors for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; human plasma protein for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; blood protein fractions for the treatment or prevention of shock, for treatment of burns, trauma, hypoalbuminemia, liver failure, ascites management, immune deficiencies, immunodeficiency, autoimmune diseases, passive immunity against specific pathogens, namely tetanus immune globulin, rabies immune globulin; blood protein fractions for coagulation for the treatment of haemophilia, Von Willebrand disease, fibrinogen deficiency, bleeding disorders; blood protein fractions for fibrinogen and thrombin to promote clot formation, reduce bleeding and to aid wound closure; blood protein fractions for diagnostic applications for antibodies for assays; endogenous antigens for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; exogenous antigens for use as vaccines and baits for screening studies during drug discovery; DNA synthesis inhibitors for use in oncology and reproductive indications, ad to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; antibodies for medical purposes; regulatory proteins for medical use for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; RNA synthesis inhibitors for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; mRNA vaccines; synthetic peptides for pharmaceutical purposes for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; antigens for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries }; mycolic acid synthesis inhibitors for the treatment of mycobacterial infections, tuberculosis and leprosy and to support treatment of drug resistant tuberculosis; preparations for detecting mutation in prion genes for medical purposes; viral antigens for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; hormone preparations for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; viral vaccines; human vaccine preparations; AAV viral vector and recombinant protein for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; genetic vectors for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries; chemical preparations for use in DNA analysis for medical purposes; therapeutic DNA and mRNA for use in oncology and reproductive indications, and to treat autoimmune diseases, blood diseases, in-born errors of metabolism, infection by pathogenic bacteria and viruses, hormone related disease, bone injuries.
Goods and ServicesCollection of information into computer databases, particularly commercial, scientific, health, gene and cell information; collection of data into computer databases, particularly commercial, scientific, health, gene and cell data; computerized database management; computerized file management; management of files and records related to the health status of individuals, molecules and formulation for medical use, as well as medicines and medical research; management of computerized files, namely, data retrieval services; statistical information compilation services into computer databases; data processing services; data processing via computer; management of computer files and data stored in electronic format, on hardware, and i n products for medical and non-medical research and analysis; management of computerized files, namely, collating and maintaining computer files and data in electronic format, in the field of materials and products for medical and non-medical research and analysis; promoting the services of others by the bringing together, for third parties, of service offers relating to capture, collection, analysis, processing and use of data, particularly medical, health gene and cell research data; computerized database management services, namely, data capture, collection, of data, particularly health, gene and cell data; data processing services, namely, processing of data, particularly health, gene and cell data; data analysis for business purposes and use of data being data analysis for business purposes, particularly health, gene and cell data; information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field; compilation of scientific and technical information into computer databases; compilation of information into computer databases related to people's health, to medicines i n the nature of medical information and to gene and cell therapy; compilation of medical reports, medical prescriptions and recommendations in the nature of medical information into computer databases; information and advice concerning all the aforesaid services.
Goods and ServicesStructural and functional analysis of genomes; genetic fingerprinting; genetic research; research in the field of gene therapy; laboratory research in the field of gene expression; analysis in the field of molecular biology for research purposes; biochemical analysis for research purposes; research and development services in the field of gene expression systems; research and development services in the field of genes and cells; biotechnology research; scientific research in the field of genetics and genetic engineering; biological analysis for research purposes; genetic mapping for scientific purposes; genetic engineering services; biotechnology testing, namely, testing in the field of biopharmaceutical development; biochemical research and development; scientific and technical analysis and research in the field of biotechnology; computer testing and analysis, namely, testing and analysis of computer systems; quality control for others and auditing in the nature technical analysis and evaluation of manufacturing processes for others; quality control of software, scientific and technical data and scientific and technical analyses; design of technical and scientific studies; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and software, particularly for artificial intelligence and decision support systems; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and computer software and platforms for consulting, analyzing, exchanging and sharing data, particularly in a collaborative work environment; scientific research in the field of design, development, formulation, updating in the nature of developing and testing of new medicines and new medicine formulas; quality control for others in the nature of evaluation of the performance of medical treatments; design and development, including selection and training, of models and software for gene and cell therapy; software as a service (SAAS) services featuring software for the remote provision of models for gene and cell therapy; software as a service (SAAS) services featuring software platforms for data collection, management, analysis, modelling, and sharing, and for managing laboratory workflows and research processes in the field of gene and cell therapy research and production of proteins in mammalian cells using recombinant DNA technology; software as a service (SAAS) services featuring software for data input, extraction, processing, display and storage relating to gene and cell therapy; provision of information relating to scientific technology; provision of temporary use of non-downloadable software for data processing and analysis relating to gene and cell therapy; technical writing, namely, preparation of technical and scientific manuals; technical writing, namely, preparation of technical and scientific reports; technology research in the field of biotechnology, biopharmaceuticals, gene and cell therapy; scientific research services; data analysis computer services, namely, providing temporary use of non-downloadable computer software for data analysis; computer programming services for data analysis and interpretation relating to gene and cell therapy; information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research and the medical field; stem cell research services; stem cell research; advisory services relating to gene therapy research; cell separation technology research services; cell separation research services; biotechnology research for determining the neuronal survival of molecules in animal models; biological cloning services; research and development of vaccines and medicines; laboratory services relating to the production of monoclonal antibodies; research in the field of cell therapy.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSYNGENSYS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, April 3, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 4, 2025APPLICATION FILING RECEIPT MAILED
Thursday, June 5, 2025ASSIGNED TO EXAMINER
Tuesday, June 10, 2025NON-FINAL ACTION WRITTEN
Wednesday, June 11, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 2, 2025REFUSAL PROCESSED BY MPU
Saturday, August 2, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 23, 2025REFUSAL PROCESSED BY IB
Thursday, January 29, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 29, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 29, 2026TEAS/EMAIL CORRESPONDENCE ENTERED